Author
Listed:
- Henning Jacobsen
(Leibniz Institute for Experimental Virology)
- Kerstin Walendy-Gnirß
(Leibniz Institute for Experimental Virology)
- Nilgün Tekin-Bubenheim
(Leibniz Institute for Experimental Virology)
- Nancy Mounogou Kouassi
(Leibniz Institute for Experimental Virology)
- Isabel Ben-Batalla
(University Medical Center Hamburg-Eppendorf
University Medical Center Hamburg-Eppendorf)
- Nikolaus Berenbrok
(University Medical Center Hamburg-Eppendorf
University Medical Center Hamburg-Eppendorf)
- Martin Wolff
(Member of the German Center for Lung Research (DZL))
- Vinicius Pinho Reis
(Leibniz Institute for Experimental Virology)
- Martin Zickler
(Leibniz Institute for Experimental Virology)
- Lucas Scholl
(Leibniz Institute for Experimental Virology)
- Annette Gries
(Leibniz Institute for Experimental Virology)
- Hanna Jania
(Leibniz Institute for Experimental Virology)
- Andreas Kloetgen
(Helmholtz Centre for Infection Research)
- Arne Düsedau
(Leibniz-Institute for Experimental Virology)
- Gundula Pilnitz-Stolze
(Leibniz-Institute for Experimental Virology)
- Aicha Jeridi
(Helmholtz Center Munich, German Research Center for Environmental Health
Member of The German Center for Lung Research (DZL))
- Ali Önder Yildirim
(Helmholtz Center Munich, German Research Center for Environmental Health
Member of The German Center for Lung Research (DZL))
- Helmut Fuchs
(Helmholtz Center Munich, German Research Center for Environmental Health)
- Valerie Gailus-Durner
(Helmholtz Center Munich, German Research Center for Environmental Health)
- Claudia Stoeger
(Helmholtz Center Munich, German Research Center for Environmental Health)
- Martin Hrabe Angelis
(Helmholtz Center Munich, German Research Center for Environmental Health
Technische Universität München
German Center for Diabetes Research (DZD))
- Tatjana Manuylova
(University Hospital Tübingen)
- Karin Klingel
(University Hospital Tübingen)
- Fiona J. Culley
(Imperial College London)
- Jochen Behrends
(Research Center Borstel, Leibniz Lung Center)
- Sonja Loges
(University Medical Center Hamburg-Eppendorf
German Cancer Research Center (DKFZ)
University Hospital Mannheim, University of Heidelberg)
- Bianca Schneider
(Research Center Borstel, Leibniz Lung Center)
- Susanne Krauss-Etschmann
(Member of the German Center for Lung Research (DZL)
Christian-Albrechts-Universität zu Kiel)
- Peter Openshaw
(Imperial College London)
- Gülsah Gabriel
(Leibniz Institute for Experimental Virology
University for Veterinary Medicine Hannover
German Center for Infection Research (DZIF))
Abstract
Influenza during pregnancy can affect the health of offspring in later life, among which neurocognitive disorders are among the best described. Here, we investigate whether maternal influenza infection has adverse effects on immune responses in offspring. We establish a two-hit mouse model to study the effect of maternal influenza A virus infection (first hit) on vulnerability of offspring to heterologous infections (second hit) in later life. Offspring born to influenza A virus infected mothers are stunted in growth and more vulnerable to heterologous infections (influenza B virus and MRSA) than those born to PBS- or poly(I:C)-treated mothers. Enhanced vulnerability to infection in neonates is associated with reduced haematopoetic development and immune responses. In particular, alveolar macrophages of offspring exposed to maternal influenza have reduced capacity to clear second hit pathogens. This impaired pathogen clearance is partially reversed by adoptive transfer of alveolar macrophages from healthy offspring born to uninfected dams. These findings suggest that maternal influenza infection may impair immune ontogeny and increase susceptibility to early life infections of offspring.
Suggested Citation
Henning Jacobsen & Kerstin Walendy-Gnirß & Nilgün Tekin-Bubenheim & Nancy Mounogou Kouassi & Isabel Ben-Batalla & Nikolaus Berenbrok & Martin Wolff & Vinicius Pinho Reis & Martin Zickler & Lucas Schol, 2021.
"Offspring born to influenza A virus infected pregnant mice have increased susceptibility to viral and bacterial infections in early life,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25220-3
DOI: 10.1038/s41467-021-25220-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25220-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.